BENVENUTO   |   Login   |   Registrati   |
Imposta Come Homepage   |   Ricerca Avanzata  CERCA  

Henry Miller: Articoli scritti

Henry I. Miller, medico e biologo molecolare, è ricercatore alla Hoover Institution della Stanford University e membro del Competitive Enterprise Institute. Le sue ricerche sono centrate sulle politiche che riguardano la scienza e la tecnologia ed includono lo sviluppo farmacologico, le nuove biotecnologie, i modelli per la riforma dei regolamenti e le emergenze causate da nuove malattie virali. Prima di entrare alla Stanford University, Miller ha ricoperto diversi incarichi nella Food and Drug Administration. Henry I. Miller is a physician and molecular biologist. He is a research fellow at Stanford University's Hoover Institution, where his research focuses on public policy toward science and technology. It encompasses a number of areas, including pharmaceutical development, the new biotechnology, models for regulatory reform, and the emergence of new viral diseases. Dr. Miller is also member of the Competitive Enterprise Insitute, and prior to join Stanford University he served in a number of posts at the Food and Drug Administration.


MALARIA/ Utterly Repellent

In the absence of effective vaccines or new anti-malarial drugs - and the funding and infrastructure to deliver them - the decision to totally phase-out DDT by the early 2020s is tantamount to ...

U.S./ Feds freeze out frost antidote

Losses to American farmers from frosts average in the billions of dollars annually. In the early 1980s, scientists at the University of California and in industry devised an ingenious approach to ...

FOOD/ GM wheat is on its way

Five years after scrapping its trials, Monsanto calculates that the time is now ripe for GM wheat to make a comeback, but Monsanto and the US wheat industry may already have been relegated to the ...

BEYOND COPENHAGEN/ Survival Of The Fittest

Often it's wiser to try to adapt to or mitigate a problem than to try to remove its causes. In society, as in biology, survival demands adaptation. In the short term, we should focus our efforts ...

DRUGS/ How Similar Are Biosimilars?

Politicians have devised various scenarios for lowering expenditures and to reduce the estimated costs of health care reform. One of these is a regulatory pathway for generic versions of a class ...

HUNGER/ Hypocrisy and the U.N.

U.N. agencies, programs and policies themselves have prevented farmers in the developing world from obtaining the tools they need to become more productive. The highly politicized and excessive ...

US/ Science and Technology Are Essential to Economic Recovery

No matter how effective stimulus packages and strategies may be, recovery from the present downturn will be plagued by government regulation that is damaging the ability of industry to perform the ...
Per gli articoli più vecchi non presenti in elenco usa il motore di ricerca Qui